Challenges in Translating iPSC Technology
Dr. James Wells moderates a panel discussion on the biggest challenges in translating organoid-based cell therapies and the steps needed to bring these technologies to market in an efficient and patient-first manner.
Publish Date: June 17, 2019
Views: 0
Related Multimedia
-
53:18Potential Applications of ALDH Bright Cells In Regenerative Medicine
Publish Date: May 27, 2011 -
56:31Modeling Human Gastrointestinal Development and Disease Using Pluripotent Stem Cells
Publish Date: March 06, 2017 -
10:08CRISPR-Cas9 Gene Editing of Cerebral Organoids to Model Microcephaly
Publish Date: February 25, 2019
Explore Our Products
-
HepatiCult™ Organoid Growth Medium (Mouse)
Cell culture medium for establishment and maintenance of mouse hepatic progenitor organoids -
Cryopreserved mouse hepatic progenitor organoids for establishment of organoid cultures -
STEMdiff™ Intestinal Organoid Kit
Serum-free medium kit for establishment and maintenance of human intestinal organoids from hPSCs -
Serum-free medium kit for the culture of kidney organoids from hPSCs